Biblio
Found 212 results
Author Keyword Title Type [ Year] Filters: First Letter Of Last Name is R [Clear All Filters]
“Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.”, Neurology, vol. 43, no. 2, pp. 250-60, 1993.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
, “Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.”, Acta Neuropathol, vol. 105, no. 5, pp. 484-8, 2003.
, “Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.”, Am J Hum Genet, vol. 73, no. 5, pp. 1041-51, 2003.
, “Analysis of European mitochondrial haplogroups with Alzheimer disease risk.”, Neurosci Lett, vol. 365, no. 1, pp. 28-32, 2004.
, “Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.”, Neurogenetics, vol. 5, no. 4, pp. 201-8, 2004.
, “Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.”, Nature, vol. 429, no. 6987, pp. 75-9, 2004.
, “Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.”, Mol Psychiatry, vol. 9, no. 11, pp. 1042-51, 2004.
, “Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.”, Mol Psychiatry, vol. 9, no. 11, pp. 1042-51, 2004.
, “Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.”, Hum Mol Genet, vol. 14, no. 3, pp. 447-60, 2005.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “A survey of genetic human cortical gene expression.”, Nat Genet, vol. 39, no. 12, pp. 1494-9, 2007.
, “A survey of genetic human cortical gene expression.”, Nat Genet, vol. 39, no. 12, pp. 1494-9, 2007.
, “Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.”, Neurogenetics, vol. 9, no. 1, pp. 51-60, 2008.
, “Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.”, Neurogenetics, vol. 9, no. 2, pp. 127-38, 2008.
, “Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.”, Am J Hum Genet, vol. 83, no. 5, pp. 623-32, 2008.
, “The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease.”, Curr Neurol Neurosci Rep, vol. 8, no. 5, pp. 384-91, 2008.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.”, Nat Genet, vol. 41, no. 10, pp. 1088-93, 2009.
, “Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.”, Nat Genet, vol. 41, no. 10, pp. 1088-93, 2009.
,